Is Appian Corporation a good investment?
Appian Corporation (APPN) is currently trading at 54.51 USD.
Market analysts have a consensus price target of 54.80 USD.
This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 1348.00.
This high multiple suggests investors have priced in significant future growth expectations.
Earnings Schedule:
Appian Corporation is expected to release its next earnings report on Feb. 18, 2027.
The market consensus estimate for Forward EPS is 1.60.
Company Profile
Appian Corporation operates as a software company in the United States, Australia, Canada, France, Germany, India, Italy, Japan, Mexico, the Netherlands, Portugal, Singapore, Spain, Sweden, Switzerland, the United Kingdom, and internationally. The company offers The Appian Platform, an integrated automation platform that enables organizations to design, automate, and optimize critical business processes. The company also offers cloud subscriptions bundled with maintenance and support and hosting services, license subscriptions, and maintenance and support for license subscriptions; and professional and customer support services. In addition, the company offers platforms, such as artificial intelligence, low-code, data fabric, process automation, intelligent document processing, process mining, process intelligence, and case management studio; and solutions, including federal acquisition, public sector case management, state and local e-procurement, contract lifecycle management, insurance connected underwriting, and insurance claims processing. It serves financial services, government, life sciences, insurance, manufacturing, energy, healthcare, telecommunications, and transportation industries. The company has a collaboration with Deloitte Touche Tohmatsu Limited for the development of AI-Powered Policing solutions. Appian Corporation forms strategic partnership with PSI CRO to advance an AI-driven process orchestration solution that automates clinical trial site identification and selection across therapeutic areas, indications, and geographies. Appian Corporation was incorporated in 1999 and is headquartered in McLean, Virginia.
Community Discussion